We have shown previously that the extracellular sequences of the human insulin receptor (IR) and the insulin-like growth factor I receptor (IGFR) have an inhibitory effect on protein tyrosine kinase (PTK) activity and on the biological functions of their respective Gag-receptor fusion proteins. To study the role of IGFR carboxyl sequence in modulation of the Gag-IGFR PTK and biological activities, five mutants, CM1, CM2, CM3, CM4, and CM5, containing carboxyl deletions of 17, 27, 47, 67, and 88 amino acids (aa), respectively, were constructed from the parental virus UIGFR encoding the Gag-IGFR. Deletion of up to 27 aa had little effect on the cell-transforming and PTK activities of UIGFR. Deletions of 47 aa in CM3 abolished PTK and transforming activities. Surprisingly, a further deletion of 20 aa in CM4 beyond that in CM3 reactivated the kinase and transforming activities. CM5, containing a deletion of 20 aa beyond that in CM4, had only marginal transforming and PTK activities. We conclude that deletion of the carboxyl region of the Gag-IGFR inactivates, instead of activating as in the case with Gag-IR, its transforming activity and the amino acid sequence 1250 to 1310 is essential for PTK and transforming activities. Analysis of the ability of the full-length IGFR and its mutant receptors described above to associate with phosphatidylinositol 3 kinase indicated that the association required PTK activity and tyrosine phosphorylation of the receptors and correlated well with their transforming activities. The carboxyl 88 aa are not essential for the association.
Protein tyrosine kinase (PTK) receptors share significant amino acid sequence homology in their PTK domains, yet they have distinctive pathways for signal transduction (3, 11) . The specificity of signal transduction by PTK receptors may involve sequences in the juxtamembrane region (1, 13, 24) , kinase insert region (9) , and/or carboxyl-terminal sequences following the PTK domain. Carboxyl-terminal sequences appear to be the most divergent regions among PTK receptors. Deletion of C-terminal sequences has been found to be a common mechanism for activation of proto-oncogenes like erbB, fms, and kit (2, 6, 7) . The C-terminal deletions frequently include important autophosphorylation sites.
The role of the C-terminal tail of the human insulin receptor (IR) in signal transduction has been investigated in both rat-i and Chinese hamster cells (CHO) by deletion of its C-terminal 43 amino acids (aa) (18) (19) (20) 27) or by specific mutation of the two tyrosine residues (positions 1316 and 1322) to phenylalanines (26) . These studies suggest that the IR C-terminal 43 aa play a positive role in the receptor's metabolic function but have a negative role in its mitogenic activity and have no effect on the receptor's PTK activity.
The IR, the insulin-like growth factor I receptor (IGFR), and the IR-related receptor (IRR) (25) are three closely related PTK receptors. We have previously shown that the extracellular sequences of human IR and IGFR have negative regulatory effects on their tyrosine kinase activities and biological functions (15, 16, 22, 29) . Both truncated PTK receptors have constitutively activated PTK and oncogenicity. However, no information regarding the role of the IGFR C terminus in modulation of its PTK activity and signal transduction is available. Even though the PTK domains of IR, IGFR, and IRR have over 80% identity in their amino acid sequences, their carboxyl sequences are only 19 to 45% homologous (25) . This finding implies that their C-terminal sequences might have different roles in modulation of their PTK activity and signal transduction.
In this study we investigated the role of the IGFR Cterminal sequence in modulating biological functions and biochemical properties of the IGFR PTK.
Biological functions of IGFR carboxyl mutants (CM). The IGFR C terminus contains 108 aa residues downstream of the PTK domain (28) , 88 aa of which were sequentially deleted from the Gag-IGFR-encoding virus UIGFR that we constructed previously (15) . CM1 contains a deletion of the C-terminal 17 aa. CM2 lacks an additional 10 aa (total of 27 aa) which includes a conserved YXXM motif (YAHM) involved in phosphatidylinositol 3 kinase (PI 3-kinase) binding (3) . This 10 aa is highly conserved in the human IR C terminus but is absent in the IRR (25, 28) . CM3 contains a further deletion of 20 aa (total of 47 aa). This 20-aa sequence (aa 1291 to 1310) is the most divergent region among the C termini of IGFR, IR, and IRR (25, 28) . CM4 has a further 20-aa deletion (aa 1271 to 1290) beyond that in CM3, resulting in a total deletion of 67 aa. CM5 lacks the C-terminal 88 aa. The additional 21-aa deletion (aa 1250 to 1270) in CM5 has two consecutive tyrosine residues (1250 and 1251) which are absent in the human IR but are conserved in the IRR (25) . This 21-aa sequence is remarkably rich in charged amino acids (Fig. 1) .
The plasmids containing the proviral recombinants were transfected into primary chicken embryo fibroblasts (CEF) as described before (15) . CM1, CM2, and CM4 induced morphological transformation of primary CEF about 2 weeks after DNA transfection. The transformed CEF became morphologically elongated (fusiform) and refractile (Fig. 2) recognizable morphological change. The CM were further assessed for their ability to promote anchorage-independent growth of transfected CEF. When compared with parental UIGFR-transfected CEF, CM1-and CM4-transfected CEF had a similar colony formation potency, whereas CM2 seemed to be slightly weaker (fewer and smaller colonies) than UIGFR; CM3 failed to induce colony formation of transfected cells, but CM5 reproducibly caused the formation of clearly recognizable but tiny colonies after a longer latent period (around 4 weeks) (Fig. 2) . The CM were injected into the wing webs of 1-to 3-day-old chickens to assay their tumorigenicity. None induced tumors up to 10 weeks after injection. Surprisingly, 60% of CM4-injected chickens (9 of 15) developed tiny tumor nodules (about 5 mm in diameter) which became apparent about 9 to 10 weeks after injection. The tumors grew very slowly. The tumor-bearing chickens were physically healthy and never succumbed to the tumors. The cell-transforming and weak tumorigenic activity of CM4, with the 67-aa deletion, is surprising since CM3, with a 47-aa deletion, lost all activity. To exclude the possibility that unexpected mutation outside the polymerase chain reaction (PCR)-derived region in pCM4 was responsible for the observed biological activity, the CM4 fragment derived from PCR was confirmed by sequencing and subcloned into the pCM3 backbone, replacing the CM3 fragment. The newly derived pCM4 in a pCM3 background demonstrated same biological and PTK activities as the original pCM4 and has been used ever since. The possibility that a further mutation(s) of CM4 in vivo was responsible for the observed weak tumorigenicity seems unlikely, since viruses recovered from CM4-induced tumor tissues, CM4t, had a similar latency (9 weeks) and incidence (50%) for tumor development. An in vivo-derived tumorigenic mutant would have resulted in a markedly shorter latency (10 to 14 days) and 100% incidence of tumorigenicity as observed in other cases (12, 17) . Besides, the CM4t-encoded Gag-IGFR protein had identical sodium dodecyl sulfate-polyacrylamide gel electrophoretic (SDS-PAGE) mobility to that of CM4 (data not shown). Therefore, the observed transforming activity of CM4 (Fig. 3C) . The lower autophosphorylation signal of PCM4 was apparently due to the fact that less PCM4 was brought down by the ctIB antiserum (Fig. 3A) . The (10, 15) . Avian sarcoma virus UR2-associated helper virus UR2AV and its molecular clone have been described previously (21) . CEF were transfected with pCM plasmids containing CM DNAs together with SacI-digested pUR2AV. The transfected CEF were transferred at 3-to 4-day intervals and overlaid with soft agar medium after each transfer to enhance the transformed cells. Recovery of viruses from transfected CEF and tumors was done as described previously (16) . Viruses recovered from CM-transfected cells were named CM1, CM2, CM3, CM4, and CM5, correspondingly. The pictures were taken 2 weeks after transfection. (B) Colony formation by transfected CEF. Equal numbers of normal or uniformly infected CEF were plated in soft agar medium for assaying the anchorage-independent growth. Pictures were taken 3 weeks after plating. their transforming activities. The C-terminal 47 aa of human IGFR, unlike the corresponding 43 aa of human IR, is of primary importance for the PTK activity of the Gag-IGFR.
The (D) . These procedures were done as described previously (15) . Lanes: C, CEF; UI, UIGFR; 1 to 5, CMI through CM5, respectively. the upstream 20-aa sequence (residues 1271 to 1290) may be involved in a negative modulation. Removal of this latter 20 aa thus restored the Gag-IGFR PTK and transforming activities lost in CM3. Alternatively, deletion of the 20 aa (residues 1271 to 1290) in CM4 may simply result in a compensatory effect on the misfolded CM3 protein such that an active conformation of the molecule is restored. The 21-aa residues adjacent to the putative PTK domain (residues 1250 to 1270, additional deletion in CM5) seems to be also important for the PTK and cell-transforming activities of the Gag-IGFR. The 21 aa further deleted in CM5 are remarkably rich in acidic residues and contain two consecutive tyrosine residues (tyrosine 1250 and 1251). The twin tyrosine residues are absent in the corresponding region of JR (28) . Interestingly, the sequence including the twin tyrosine residues is identical to that of the JRR (25) . Whether these twin tyrosine residues play any role in regulating IGFR PTK remains to be elucidated. In general, in vitro and intracellular PTK activities correlate well with the celltransforming activity of the mutants.
The CM3 mutant lacking the C-terminal 47 aa is structurally similar to an JR mutant with a C-terminal 43-aa deletion (18) (19) (20) 27 (23) . A mutant containing a 74-aa deletion in the PDGFR C terminus of the chimera had a low level of tyrosine phosphorylation and lost completely the oncogenic potential, whereas an additional 6-aa deletion restored the receptor phosphorylation and transforming activities to the wild-type level. Further deletion of 35 aa (115-aa deletion) yielded a receptor with little PTK or biological activity. The biological and biochemical activities of those three chimeric mutants are very similar to those of the mutants CM3, CM4, and CM5. Although the sequences of the IGFR and PDGFR carboxyl tails are very different, these regions seem to have similar modulatory effects on the biological and biochemical properties of these receptors.
Phosphorylation of cellular proteins by CM. To evaluate tyrosine phosphorylation of cellular proteins by the CM PTKs, total cell lysates of transfected CEF were analyzed by immunoblotting with the anti-p-tyr antibodies PT22 and PY20. Cells cultured in parallel were labeled with [35S]methionine to monitor the mutant IGFR proteins. The result of metabolic labeling was similar to that shown in Fig. 3A and SC, indicating that a comparable amount of mutant IGFR protein was expressed in the infected CEF. The overall tyrosine phosphorylation of cellular proteins was markedly increased in cells transfected by CM1, CM2, and CM4 (Fig. 4) . As expected, cellular proteins from the CM3-infected CEF did not have a significant increase in tyrosine phosphorylation. However, the CM5-infected CEF appeared to have slightly elevated tyrosine phosphorylation of cellular proteins. Low levels of autophosphorylation (Fig. 3D) and phosphorylation of cellular proteins (Fig. 4 ) by PCM5 correlate with its weak transforming activity. Overall, the extent of tyrosine phosphorylation of cellular proteins correlates with the CEF-transforming activities of the CM mutants. (16) . The phosphoinositol phosphate (PIP) products were analyzed on thin-layer chromatography plates (A and B) (16) . The level of fusion protein expression was monitored by [35Sl methionine labeling as described in the legend to Fig. 3 (C) . PIP and protein bands were visualized by autoradiography, with exposure times within the linear range of the signals. Lanes: C, CEF; UI, UIGFR; to 5, CMI to CM5, respectively. To study PI 3-kinase association with full-length IGFR proteins, the full-length IGFR-transformed CEF were incubated overnight in serum-free FlO medium and stimulated with (+) or without ( -) human IGF-l (I5). One half of the cell lysates was immunoprecipitated with oIB, the other half was immunoprecipitated with PY20. Each immunoprecipitate was further divided into three aliquots. One aliquot was used for PI 3-kinase assay (D), the second aliquot was analyzed for IGFR tyrosine phosphorylation by immunoblotting with monoclonal anti-p-tyr antibody PY20 (E), and the third aliquot was analyzed for IGFR protein amount by immunoblotting with o.B (F). The positions of the 180-kDa IGFR precursor and the 95-kDa IGFR ,B subunit are indicated.
Association of PI 3-kinase with IGFR proteins. Association of PTK proteins with PI 3-kinase has been implicated in cellular transformation by PTK oncogenes (3) . The association of the PI 3-kinase activity with that of N-terminally truncated IGFR mutants described previously correlated with their transforming ability (16) . We therefore studied the PI 3-kinase association with CM proteins. When normalized to the mutant IGFR protein amounts in the immunoprecipitates (Fig. SC) , it appeared that PCM1, PCM2, and PCM4 had comparable levels of associated PI 3-kinase activity as that of p57-75UICFR, whereas PCM3 had negligible associated PI 3-kinase activity (Fig. 5 ). PCMS had a significant level of associated PI 3-kinase activity in the regular but not in the serum-free culture medium ( Fig. SA and B) . The amount of PI 3-kinase activity associated with UIGFR, PCM1, PCM2, and PCM4 was also decreased under serum-free conditions but not as drastically as for PCMS (Fig. SB) .
The PTK-positive CMI, CM2, and CM4 proteins were able to associate with PI 3-kinase, whereas the PTK-negative or weak CM3 and CMS proteins either failed to associate or associated only poorly with the PI 3-kinase. Thus, the association of PI 3-kinase with Gag-IGFR proteins appears to require PTK activity and/or tyrosine phosphorylation of the fusion proteins. This relationship was investigated by using native IGFR, since its PTK activity and tyrosine phosphorylation can be regulated. The PI 3-kinase activity associated with IGFR increased more than 20-fold after stimulation of IGFRoverexpressing CEF with recombinant human insulin-like growth factor I (IGF-1) (Fig. SD) . Most of the anti-p-tyr antibody-precipitated PI 3-kinase was also brought down by the anti-IGFR antiserum (Fig. SD) , indicating that the observed PI 3-kinase activity was mostly associated with tyrosine- 'Tumorigenicity is expressed as number of tumor-bearing chickens per total number of chickens injected. The results for the tumorigenicity assay represent the sum of two to four independent injections for CM1, CM2, CM4, and CM5.
' See reference 15.
phosphorylated IGFR proteins. Indeed, the association of PI 3-kinase with IGFR correlated well with tyrosine phosphorylation of the receptor (Fig. 5E) . Most of the receptor proteins became tyrosine phosphorylated after IGF-1 stimulation (Fig.  5F ). We conclude that the association of PI 3-kinase with IGFR and its mutants requires PTK activity and correlates well with tyrosine phosphorylation of the native or mutant IGFR proteins. The association of PI 3-kinase with CM mutant proteins correlated well in general with their abilities to induce cell transformation (Table 1) . (14) . The differential effects of C-terminal sequences of IR and IGFR on their functions elucidated in this and other studies (18) (19) (20) 25) may bear some relevance to the distinct biological functions of these two receptors.
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